Cancer Biotherapy and Radiopharmaceuticals

2.1k papers and 33.0k indexed citations i.

About

The 2.1k papers published in Cancer Biotherapy and Radiopharmaceuticals in the last decades have received a total of 33.0k indexed citations. Papers published in Cancer Biotherapy and Radiopharmaceuticals usually cover Radiology, Nuclear Medicine and Imaging (786 papers), Molecular Biology (708 papers) and Oncology (616 papers) specifically the topics of Radiopharmaceutical Chemistry and Applications (553 papers), Medical Imaging Techniques and Applications (235 papers) and Monoclonal and Polyclonal Antibodies Research (197 papers). The most active scholars publishing in Cancer Biotherapy and Radiopharmaceuticals are Robert O. Dillman, Martin W. Brechbiel, Carolyn J. Anderson, Riccardo Ferdani, J. Harvey Turner, Kido Nwe, Michael G. Stabin, Gerald L. DeNardo, Sally J. DeNardo and Otto C. Boerman.

In The Last Decade

Fields of papers published in Cancer Biotherapy and Radiopharmaceuticals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Cancer Biotherapy and Radiopharmaceuticals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Cancer Biotherapy and Radiopharmaceuticals.

Countries where authors publish in Cancer Biotherapy and Radiopharmaceuticals

Since Specialization
Citations

This map shows the geographic impact of research published in Cancer Biotherapy and Radiopharmaceuticals. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Cancer Biotherapy and Radiopharmaceuticals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cancer Biotherapy and Radiopharmaceuticals more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025